http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33861024

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 361
issn 1573-7217
0167-6806
issueIdentifier 2
pageRange 347-361
publicationName Breast Cancer Research and Treatment
startingPage 347
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ad52aa3b4f1401d7b670fbe286569732
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_51404d5a7b1343169d4d08838a2d83a0
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_25219a2aa047a1a21c49863ef5a0ac6b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d256e83c771943cc8f18943d93b5dfd2
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3f30fdd83e5bfae858404abab19a2a93
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_338adea17c81e0a18c3f8da688def496
bibliographicCitation Liu X, Qiu R, Xu M, Meng M, Zhao S, Ji J, Yang Y. KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer. Breast Cancer Research and Treatment. 2021 Jul 08;189(2):347–61. doi: 10.1007/s10549-021-06325-1.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6975-620X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_986ac39170e3fdd89b7ae0e1724ec61d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8de52c9ca8782daac917cad772a632c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8314ebb311264866efd822a85659ff45
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_119f21d73beb9ccc54ab4cd573c077ae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e202b9a230b80c6ad8c317e7233e04d3
date 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/34240274
https://doi.org/10.1007/s10549-021-06325-1
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1254
https://portal.issn.org/resource/ISSN/0167-6806
https://portal.issn.org/resource/ISSN/1573-7217
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer
discusses http://id.nlm.nih.gov/mesh/M0022149
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9c01beddf272cfeeba59766445ea3aa9
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Total number of triples: 40.